Colon carcinogenesis: Learning from NF-κB and AP-1

被引:68
作者
Vaiopoulos, Aristides G. [1 ]
Papachroni, Katerina K. [1 ]
Papavassiliou, Athanasios G. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
关键词
Colorectal cancer; Inflammation; Signal transduction; NF-kappa B; AP-1; COLORECTAL-CANCER; TRANSCRIPTION FACTOR; ACTIVATOR PROTEIN-1; COX-2; EXPRESSION; TARGET GENES; CELLS; ADENOCARCINOMAS; PATHWAY; CYCLOOXYGENASE-2; PROGRESSION;
D O I
10.1016/j.biocel.2010.03.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is among the most common types of cancer attributed to genetic alterations. Its manifestation implicates NF-kappa B and AF-1 signaling pathways by virtue of their regulative role on the genetic control of cell cycle and apoptosis as well as by their capacity to be constitutively activated or exogenously induced by growth factors, cytokines, stress signals and oncoproteins. In CRC, the positive impact of NF-kappa B and AP-1 on the transcription of angiogenic and invasive factors strongly implicates these transcription factors in the transition of benign carcinomas towards a metastatic phenotype. Furthermore, the deregulated function of NF-kappa B and AP-1 in CRC cells affects inflammatory cascades, manifested by the ample production of inflammatory mediators. in this perspective, inhibition of NF-kappa B and AP-1 signaling mechanisms has become a rational target in the development of novel therapeutic approaches against CRC. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1061 / 1065
页数:5
相关论文
共 29 条
[1]   AP-1 and colorectal cancer [J].
Ashida R. ;
Tominaga K. ;
Sasaki E. ;
Watanabe T. ;
Fujiwara Y. ;
Oshitani N. ;
Higuchi K. ;
Mitsuyama S. ;
Iwao H. ;
Arakawa T. .
InflammoPharmacology, 2005, 13 (1-3) :113-125
[2]   Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression [J].
Basseres, D. S. ;
Baldwin, A. S. .
ONCOGENE, 2006, 25 (51) :6817-6830
[3]  
Bubici C, 2006, HISTOL HISTOPATHOL, V21, P69, DOI 10.14670/HH-21.69
[4]   Nuclear factor-κB, an unappreciated tumor suppressor [J].
Chen, Fei ;
Castranova, Vince .
CANCER RESEARCH, 2007, 67 (23) :11093-11098
[5]   Divergent role of ceramide generated by exogenous sphingomyelinases on NF-κB activation and apoptosis in human colon HT-29 cells [J].
Colell, A ;
Coll, O ;
Marí, M ;
Fernández-Checa, JC ;
García-Ruiz, C .
FEBS LETTERS, 2002, 526 (1-3) :15-20
[6]   Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells [J].
Collett, GP ;
Campbell, FC .
CARCINOGENESIS, 2004, 25 (11) :2183-2189
[7]   The role of bile acids in carcinogenesis [J].
Debruyne, PR ;
Bruyneel, EA ;
Li, XD ;
Zimber, A ;
Gespach, C ;
Mareel, MM .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 480 :359-369
[8]   Peroxisome-proliferator-activated receptor ot agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1 [J].
Grau, R ;
Punzón, C ;
Fresno, M ;
Iñiguez, MA .
BIOCHEMICAL JOURNAL, 2006, 395 :81-88
[9]   The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice [J].
Hasselblatt, P. ;
Gresh, L. ;
Kudo, H. ;
Guinea-Viniegra, J. ;
Wagner, E. F. .
ONCOGENE, 2008, 27 (47) :6102-6109
[10]   Invasion Associated Up-Regulation of Nuclear Factor κB Target Genes in Colorectal Cancer [J].
Horst, David ;
Budczies, Jan ;
Brabletz, Thomas ;
Kirchner, Thomas ;
Hlubek, Falk .
CANCER, 2009, 115 (21) :4946-4958